Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

New alopecia treatments aim for better results and fewer side effects.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Public interest in oral minoxidil for hair loss increased after a New York Times article.

Spironolactone can effectively treat hair loss with manageable side effects.

Bicalutamide may help treat female pattern hair loss.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Men can experience female pattern hair loss, needing different treatments.

Long-term glucocorticoid use can cause skin problems like easy bruising and poor wound healing, especially at higher doses.

Isotretinoin effectively reduces acne but causes dry skin, higher skin pH, more redness, and hair loss.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.